Evidence-based medicine: The design and interpretation of noninferiority clinical trials in veterinary medicine

K. J. Freise, T. L. Lin, T. M. Fan, V. Recta, T. P. Clark

Research output: Contribution to journalReview article

Abstract

Noninferiority trials are clinical studies designed to demonstrate that an investigational drug is at least as effective as an established treatment within a predetermined margin. They are conducted, in part, because of ethical concerns of administering a placebo to veterinary patients when an established effective treatment exists. The use of noninferiority trial designs has become more common in veterinary medicine with the increasing number of established veterinary therapeutics and the desire to eliminate potential pain or distress in a placebo-controlled study. Selecting the appropriate active control and an a priori noninferiority margin between the investigational and active control drug are unique and critical design factors for noninferiority studies. Without reliable historical knowledge of the disease response in the absence of treatment and of the response to the selected active control drug, proper design and interpretation of a noninferiority trial is not possible. Despite the appeal of conducting noninferiority trials to eliminate ethical concerns of placebo-controlled studies, there are real limitations and possible ethical conundrums associated with noninferiority trials. The consequences of incorrect study conclusions because of poor noninferiority trial design need careful attention. Alternative trial designs to typical noninferiority studies exist, but these too have limitations and must also be carefully considered.

Original languageEnglish (US)
Pages (from-to)1305-1317
Number of pages13
JournalJournal of veterinary internal medicine
Volume27
Issue number6
DOIs
StatePublished - Nov 1 2013

Fingerprint

Veterinary Medicine
Evidence-Based Medicine
veterinary medicine
clinical trials
medicine
Clinical Trials
Placebos
placebos
drugs
Investigational Drugs
Drug and Narcotic Control
Drug Design
Therapeutics
distress
pain
Pain
therapeutics

Keywords

  • Ethics
  • Placebo
  • Positive control
  • Statistical methods

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Evidence-based medicine : The design and interpretation of noninferiority clinical trials in veterinary medicine. / Freise, K. J.; Lin, T. L.; Fan, T. M.; Recta, V.; Clark, T. P.

In: Journal of veterinary internal medicine, Vol. 27, No. 6, 01.11.2013, p. 1305-1317.

Research output: Contribution to journalReview article

@article{f3965156df3249ad897acb6283bcecd8,
title = "Evidence-based medicine: The design and interpretation of noninferiority clinical trials in veterinary medicine",
abstract = "Noninferiority trials are clinical studies designed to demonstrate that an investigational drug is at least as effective as an established treatment within a predetermined margin. They are conducted, in part, because of ethical concerns of administering a placebo to veterinary patients when an established effective treatment exists. The use of noninferiority trial designs has become more common in veterinary medicine with the increasing number of established veterinary therapeutics and the desire to eliminate potential pain or distress in a placebo-controlled study. Selecting the appropriate active control and an a priori noninferiority margin between the investigational and active control drug are unique and critical design factors for noninferiority studies. Without reliable historical knowledge of the disease response in the absence of treatment and of the response to the selected active control drug, proper design and interpretation of a noninferiority trial is not possible. Despite the appeal of conducting noninferiority trials to eliminate ethical concerns of placebo-controlled studies, there are real limitations and possible ethical conundrums associated with noninferiority trials. The consequences of incorrect study conclusions because of poor noninferiority trial design need careful attention. Alternative trial designs to typical noninferiority studies exist, but these too have limitations and must also be carefully considered.",
keywords = "Ethics, Placebo, Positive control, Statistical methods",
author = "Freise, {K. J.} and Lin, {T. L.} and Fan, {T. M.} and V. Recta and Clark, {T. P.}",
year = "2013",
month = "11",
day = "1",
doi = "10.1111/jvim.12211",
language = "English (US)",
volume = "27",
pages = "1305--1317",
journal = "Journal of Veterinary Internal Medicine",
issn = "0891-6640",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Evidence-based medicine

T2 - The design and interpretation of noninferiority clinical trials in veterinary medicine

AU - Freise, K. J.

AU - Lin, T. L.

AU - Fan, T. M.

AU - Recta, V.

AU - Clark, T. P.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Noninferiority trials are clinical studies designed to demonstrate that an investigational drug is at least as effective as an established treatment within a predetermined margin. They are conducted, in part, because of ethical concerns of administering a placebo to veterinary patients when an established effective treatment exists. The use of noninferiority trial designs has become more common in veterinary medicine with the increasing number of established veterinary therapeutics and the desire to eliminate potential pain or distress in a placebo-controlled study. Selecting the appropriate active control and an a priori noninferiority margin between the investigational and active control drug are unique and critical design factors for noninferiority studies. Without reliable historical knowledge of the disease response in the absence of treatment and of the response to the selected active control drug, proper design and interpretation of a noninferiority trial is not possible. Despite the appeal of conducting noninferiority trials to eliminate ethical concerns of placebo-controlled studies, there are real limitations and possible ethical conundrums associated with noninferiority trials. The consequences of incorrect study conclusions because of poor noninferiority trial design need careful attention. Alternative trial designs to typical noninferiority studies exist, but these too have limitations and must also be carefully considered.

AB - Noninferiority trials are clinical studies designed to demonstrate that an investigational drug is at least as effective as an established treatment within a predetermined margin. They are conducted, in part, because of ethical concerns of administering a placebo to veterinary patients when an established effective treatment exists. The use of noninferiority trial designs has become more common in veterinary medicine with the increasing number of established veterinary therapeutics and the desire to eliminate potential pain or distress in a placebo-controlled study. Selecting the appropriate active control and an a priori noninferiority margin between the investigational and active control drug are unique and critical design factors for noninferiority studies. Without reliable historical knowledge of the disease response in the absence of treatment and of the response to the selected active control drug, proper design and interpretation of a noninferiority trial is not possible. Despite the appeal of conducting noninferiority trials to eliminate ethical concerns of placebo-controlled studies, there are real limitations and possible ethical conundrums associated with noninferiority trials. The consequences of incorrect study conclusions because of poor noninferiority trial design need careful attention. Alternative trial designs to typical noninferiority studies exist, but these too have limitations and must also be carefully considered.

KW - Ethics

KW - Placebo

KW - Positive control

KW - Statistical methods

UR - http://www.scopus.com/inward/record.url?scp=84887618739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887618739&partnerID=8YFLogxK

U2 - 10.1111/jvim.12211

DO - 10.1111/jvim.12211

M3 - Review article

C2 - 24128266

AN - SCOPUS:84887618739

VL - 27

SP - 1305

EP - 1317

JO - Journal of Veterinary Internal Medicine

JF - Journal of Veterinary Internal Medicine

SN - 0891-6640

IS - 6

ER -